Health ❯ Healthcare ❯ Pharmaceuticals ❯ Clinical Trials

Phase 3 Trials

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

The split votes highlight regulators' push for proof that early treatment changes extend lives.

Investor Lawsuits Target Gossamer Bio Over Failed PROSERA Trial

Phase 3 Trial Finds Tukysa Improves PFS in First-Line Maintenance for HER2-Positive Metastatic Breast Cancer

FDA Approves Libtayo as First Immunotherapy for Adjuvant Treatment of High‑Risk CSCC

Lilly’s Orforglipron Pill Hits Phase 3 Goals and Outperforms Oral Semaglutide in Diabetes Study